244 related articles for article (PubMed ID: 14761355)
1. [Renal dysfunction in workers exposed to arsenic and cadmium].
Hong F; Jin TY; Lu GD; Yin ZY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Dec; 21(6):432-6. PubMed ID: 14761355
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of cadmium and arsenic interactions.
Nordberg GF; Jin T; Hong F; Zhang A; Buchet JP; Bernard A
Toxicol Appl Pharmacol; 2005 Aug; 206(2):191-7. PubMed ID: 15967208
[TBL] [Abstract][Full Text] [Related]
3. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method].
Hong F; Jin TY; Zhang AH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):374-8. PubMed ID: 15569507
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between plasma anti-metallothionein antibody and renal dysfunction in cadmium exposed workers].
Chen L; Jin TY; Chang XL; Lei LJ; Zhou YF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):7-11. PubMed ID: 16600085
[TBL] [Abstract][Full Text] [Related]
5. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China.
Chen L; Jin T; Huang B; Nordberg G; Nordberg M
Toxicol Appl Pharmacol; 2006 Aug; 215(1):93-9. PubMed ID: 16510161
[TBL] [Abstract][Full Text] [Related]
6. Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters.
Lei LJ; Chen L; Jin TY; Nordberg M; Chang XL
Toxicol Sci; 2007 May; 97(1):189-95. PubMed ID: 17303580
[TBL] [Abstract][Full Text] [Related]
7. Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China.
Chen L; Jin T; Huang B; Chang X; Lei L; Nordberg GF; Nordberg M
Toxicol Sci; 2006 May; 91(1):104-12. PubMed ID: 16322080
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population.
Hong F; Jin T; Zhang A
Biometals; 2004 Oct; 17(5):573-80. PubMed ID: 15688868
[TBL] [Abstract][Full Text] [Related]
9. [Application of Benchmark dose (BMD) in estimating biological exposure limit (BEL)].
Shao B; Jin TY; Qian HL; Wu XW; Kong QH; Ye TT
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):20-2. PubMed ID: 16600088
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure.
Chang X; Jin T; Chen L; Nordberg M; Lei L
Exp Biol Med (Maywood); 2009 Jun; 234(6):666-72. PubMed ID: 19359654
[TBL] [Abstract][Full Text] [Related]
11. [Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes in smoking and non-smoking workers at copper foundry occupational co-exposed to arsenic cadmium and lead].
Milnerowicz H; Bizoń A; Witt K; Antonowicz-Juchniewicz J; Andrzejak R
Przegl Lek; 2008; 65(10):518-21. PubMed ID: 19189537
[TBL] [Abstract][Full Text] [Related]
12. Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead.
Sun Y; Sun D; Zhou Z; Zhu G; Lei L; Zhang H; Chang X; Jin T
Ann Occup Hyg; 2008 Aug; 52(6):527-33. PubMed ID: 18567606
[TBL] [Abstract][Full Text] [Related]
13. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
Environ Res; 2006 Jul; 101(3):401-6. PubMed ID: 16436274
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China.
Nordberg GF
Toxicol Lett; 2010 Jan; 192(1):45-9. PubMed ID: 19540908
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors.
Nordberg GF; Jin T; Wu X; Lu J; Chen L; Lei L; Hong F; Nordberg M
Biochimie; 2009 Oct; 91(10):1282-5. PubMed ID: 19563860
[TBL] [Abstract][Full Text] [Related]
16. Association between renal effects and cadmium exposure in cadmium-nonpolluted area in Japan.
Yamanaka O; Kobayashi E; Nogawa K; Suwazono Y; Sakurada I; Kido T
Environ Res; 1998 Apr; 77(1):1-8. PubMed ID: 9593622
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of low-level cadmium and arsenic on the kidney.
Huang M; Choi SJ; Kim DW; Kim NY; Park CH; Yu SD; Kim DS; Park KS; Song JS; Kim H; Choi BS; Yu IJ; Park JD
J Toxicol Environ Health A; 2009; 72(21-22):1493-8. PubMed ID: 20077223
[TBL] [Abstract][Full Text] [Related]
18. Kidney dysfunction and cadmium exposure--factors influencing dose-response relationships.
Nordberg G; Jin T; Wu X; Lu J; Chen L; Liang Y; Lei L; Hong F; Bergdahl IA; Nordberg M
J Trace Elem Med Biol; 2012 Jun; 26(2-3):197-200. PubMed ID: 22565016
[TBL] [Abstract][Full Text] [Related]
19. The reference dose for subchronic exposure of pigs to cadmium leading to early renal damage by benchmark dose method.
Wu X; Wei S; Wei Y; Guo B; Yang M; Zhao D; Liu X; Cai X
Toxicol Sci; 2012 Aug; 128(2):524-31. PubMed ID: 22610606
[TBL] [Abstract][Full Text] [Related]
20. Serum beta2-microglobulin in cadmium exposed workers.
Piscator M
Pathol Biol (Paris); 1978 Sep; 26(6):321-3. PubMed ID: 83573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
